Tango Therapeutics Valuation
| TNGX Stock | USD 3.10 0.16 5.44% |
At this time, the company appears to be overvalued. Tango Therapeutics has a current Real Value of $2.98 per share. The regular price of the company is $3.1. Our model measures the value of Tango Therapeutics from inspecting the company fundamentals such as Return On Equity of -0.49, operating margin of (2.83) %, and Shares Outstanding of 107.42 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Tango Therapeutics' valuation include:
Price Book 1.453 | Enterprise Value 77.3 M | Enterprise Value Ebitda (0.91) | Price Sales 7.6757 | Enterprise Value Revenue 1.7828 |
Overvalued
Today
Please note that Tango Therapeutics' price fluctuation is very risky at this time. Calculation of the real value of Tango Therapeutics is based on 3 months time horizon. Increasing Tango Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tango Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tango Stock. However, Tango Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.1 | Real 2.98 | Target 17.6 | Hype 3.1 | Naive 2.21 |
The intrinsic value of Tango Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tango Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tango Therapeutics helps investors to forecast how Tango stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tango Therapeutics more accurately as focusing exclusively on Tango Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tango Therapeutics' intrinsic value based on its ongoing forecasts of Tango Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tango Therapeutics' closest peers.
Tango Therapeutics Cash |
|
Tango Valuation Trend
Analysing the historical paterns of Tango Therapeutics' enterprise value and its market capitalization is a good way to estimate and gauge the value of Tango Therapeutics over time and is usually enough for investors to make rational market timing decisions.
Tango Revenue by Product
Tango Therapeutics Total Value Analysis
Tango Therapeutics is at this time forecasted to have valuation of 77.34 M with market capitalization of 333 M, debt of 38.92 M, and cash on hands of 416.36 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tango Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
77.34 M | 333 M | 38.92 M | 416.36 M |
Tango Therapeutics Investor Information
About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.45. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tango Therapeutics recorded a loss per share of 1.15. The entity had not issued any dividends in recent years. Based on the key indicators related to Tango Therapeutics' liquidity, profitability, solvency, and operating efficiency, Tango Therapeutics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Tango Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tango Therapeutics has an asset utilization ratio of 9.07 percent. This suggests that the Company is making $0.0907 for each dollar of assets. An increasing asset utilization means that Tango Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Tango Therapeutics Ownership Allocation
The majority of Tango Therapeutics outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Tango Therapeutics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Tango Therapeutics. Please pay attention to any change in the institutional holdings of Tango Therapeutics as this could imply that something significant has changed or is about to change at the company.Tango Therapeutics Profitability Analysis
The company reported the previous year's revenue of 36.53 M. Net Loss for the year was (101.74 M) with loss before overhead, payroll, taxes, and interest of (81.05 M).About Tango Therapeutics Valuation
Our relative valuation model uses a comparative analysis of Tango Therapeutics. We calculate exposure to Tango Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tango Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -78.7 M | -74.7 M | |
| Pretax Profit Margin | (2.78) | (2.92) | |
| Operating Profit Margin | (3.13) | (3.28) | |
| Net Loss | (2.79) | (2.92) | |
| Gross Profit Margin | (2.15) | (2.05) |
Tango Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 94.6 M |
Tango Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Tango Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Tango we look at many different elements of the entity such as Tango's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tango Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tango Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tango Therapeutics' worth.Additional Tools for Tango Stock Analysis
When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.